FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38087311000001105: Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Mar 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1189491000001119 Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1189501000001111 Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Product containing precisely topiramate 100 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Topiramate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 60 tablet 3 x 20 tablets Has AMP True Topiramate 100mg tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start